Evolent Health Inc [EVH] stock is trading at $12.92, down -0.08%. An important factor to consider is whether the stock is rising or falling in short-term value. The EVH shares have gain 11.48% over the last week, with a monthly amount drifted -46.48%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Evolent Health Inc [NYSE: EVH] stock has seen the most recent analyst activity on November 08, 2024, when Stephens downgraded its rating to a Equal-Weight and also revised its price target to $16 from $38. Previously, KeyBanc Capital Markets started tracking the stock with Overweight rating on October 11, 2024, and set its price target to $35. On August 09, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $33 on the stock. Citigroup started tracking the stock assigning a Buy rating and suggested a price target of $40 on April 22, 2024. Oppenheimer initiated its recommendation with a Outperform and recommended $45 as its price target on March 01, 2024. Barclays started tracking with a Overweight rating for this stock on January 03, 2024, and assigned it a price target of $39. In a note dated December 06, 2023, JMP Securities initiated an Mkt Outperform rating and provided a target price of $37 on this stock.
Evolent Health Inc [EVH] stock has fluctuated between $11.17 and $35.00 over the past year. Currently, Wall Street analysts expect the stock to reach $40.86 within the next 12 months. Evolent Health Inc [NYSE: EVH] shares were valued at $12.92 at the most recent close of the market. An investor can expect a potential return of 216.25% based on the average EVH price forecast.
Analyzing the EVH fundamentals
Evolent Health Inc [NYSE:EVH] reported sales of 2.46B for the trailing twelve months, which represents a growth of 21.60%. Gross Profit Margin for this corporation currently stands at 0.14% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.03, Equity is -0.07 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.77 points at the first support level, and at 12.62 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.14, and for the 2nd resistance point, it is at 13.36.
Ratios To Look Out For
For context, Evolent Health Inc’s Current Ratio is 1.04. On the other hand, the Quick Ratio is 1.04, and the Cash Ratio is 0.18. Considering the valuation of this stock, the price to sales ratio is 0.61, the price to book ratio is 1.43.
Transactions by insiders
Recent insider trading involved McCarthy Daniel Joseph, PRESIDENT, that happened on Aug 22 ’24 when 23693.0 shares were sold. PRESIDENT, McCarthy Daniel Joseph completed a deal on Aug 23 ’24 to sell 10469.0 shares. Meanwhile, General Counsel Weinberg Jonathan sold 42140.0 shares on Aug 22 ’24.
